Skip to main content
Signal8

Fry Hannah

SEC insider (Form 3/4/5 filer). CIK 0001938146. VP, Controller at Protara Therapeutics, Inc. (TARA). 6 reported Form 4/5 transactions since Sep 2024; latest on Jan 26, 2026. Located in NEW YORK, NY.

Companies Fry Hannah has filed insider reports for

  • Protara Therapeutics, Inc. (TARA): Officer, VP, Controller
Fry Hannah profile photo

Fry Hannah

CIK: 0001938146

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (33.3%)

Compensation grants

Other (G, F, J, C, D, …)4 (66.7%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Protara Therapeutics, Inc. logo
TARA

Protara Therapeutics, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (6 total)

  • Protara Therapeutics, Inc. logo
    TARA

    Protara Therapeutics, Inc.

    Jan 26, 2026
    Tax Payment
    Direct
    1.5K shares at avg. $6.67$10K
  • Protara Therapeutics, Inc. logo
    TARA

    Protara Therapeutics, Inc.

    Jan 20, 2026
    Tax Payment
    Direct
    2.1K shares at avg. $5.60$12K
  • Protara Therapeutics, Inc. logo
    TARA

    Protara Therapeutics, Inc.

    Jan 16, 2026
    Award
    Direct
    9.5K shares-
  • Protara Therapeutics, Inc. logo
    TARA

    Protara Therapeutics, Inc.

    Jan 24, 2025
    Award
    Direct
    9.5K shares-
  • Protara Therapeutics, Inc. logo
    TARA

    Protara Therapeutics, Inc.

    Jan 21, 2025
    Tax Payment
    Direct
    2.1K shares at avg. $4.76$10K
  • Protara Therapeutics, Inc. logo
    TARA

    Protara Therapeutics, Inc.

    Jan 3, 2025
    Tax Payment
    Direct
    394 shares at avg. $6.14$2K

1-6 of 6